EPITOPE SUMMARY | |
---|---|
GILGFVFTL is a linear peptidic epitope (epitope ID ) studied as part of Matrix protein 1 (UniProt:P03485) from Influenza A virus. This epitope has been studied for immune reactivity in publication(s), tested in T cell assays, B cell assays, MHC ligand assays and has 3D structure(s) , , , , , , , , , , and . |
CURATED EXPERIMENTAL DATA | |
---|---|
MHC Ligand Assay(s) | |
MHC molecule | Positive / All |
HLA-A*02:01 | / |
HLA-A2 | / |
HLA-A*02:06 | / |
HLA-A*02:02 | / |
HLA-A*02:03 | / |
HLA-C*08:01 | / |
HLA-A*68:02 | / |
HLA-E | / |
HLA-E*01:03 | / |
SLA-3*02:02 | / |
HLA-A*01:01 | / |
HLA-A*03:01 | / |
HLA-A*11:01 | / |
HLA-A*24:02 | / |
HLA-A3 | / |
HLA-DRA*01:01/DRB1*01:01 | / |
B Cell Assay(s) | |
Assay Type | Positive / All |
qualitative binding | / |
complement-dependent cytotoxicity | / |
T Cell Assay(s) | |
Assay Type | Positive / All |
IFNg release | / |
qualitative binding | / |
cytotoxicity | / |
dissociation constant KD | / |
proliferation | / |
TNFa release | / |
off rate | / |
on rate | / |
activation | / |
3D structure | / |
IL-2 release | / |
CCL4/MIP-1b release | / |
pathogen burden after challenge | / |
granzyme B release | / |
perforin release | / |
degranulation | / |
survival from pathogen challenge | / |
TNF release | / |
binding constant | / |
CXCL9/MIG release | / |
decreased disease | / |
IL-12 release | / |
T cell- APC binding | / |
IL-10 release | / |
IL-4 release | / |
EXTERNAL RESOURCES | |
---|---|
Resource | Link |